Pharmacovigilance is essential for the continuous monitoring of medicinal product safety and the protection of patients. However, maintaining a complete in-house pharmacovigilance structure can be challenging, particularly for smaller companies, organisations with growing portfolios or companies with changing operational needs.

Outsourcing pharmacovigilance services provides access to a specialised, flexible structure tailored to the needs of each organisation, while supporting compliance with the applicable regulatory requirements.

1. Cost optimisation

Establishing and maintaining an internal pharmacovigilance department involves costs related to specialised personnel, continuous training, information systems, procedures, documentation and regulatory monitoring.

Outsourcing can replace part of these fixed costs with a service model adjusted to the size of the product portfolio, the volume of safety cases and the activities actually required.

2. Access to specialist expertise

Pharmacovigilance service providers have qualified teams with experience across different medicinal products, markets and regulatory procedures.

By working with an external team, companies gain immediate access to specialist expertise without having to recruit, train and retain all the required professional profiles in-house.

3. Scalability of services

Pharmacovigilance needs may vary throughout the life cycle of a medicinal product. Workloads may increase during a product launch, the preparation of a PSUR, the preparation or update of an RMP, a regulatory inspection, a signal assessment or the implementation of risk-minimisation measures.

Outsourcing allows resources to be increased or reduced according to the company’s actual needs, ensuring an appropriate response during periods of increased activity.

4. Support with regulatory compliance

Pharmacovigilance is subject to strict and continuously evolving regulatory requirements. Working with an experienced provider helps ensure that activities are conducted in accordance with the applicable legislation, Good Pharmacovigilance Practices — GVP — pharmacovigilance agreements and internal procedures.

Services may include:

   - Management and submission of individual case safety reports;

   - Scientific literature monitoring;

   - Signal detection, validation and assessment;

   - Preparation and maintenance of the PSMF;

   - Preparation of PSURs/PBRERs and RMPs;

   - Reconciliations and deadline monitoring;

   - Pharmacovigilance audits and training;

   - Inspection preparation and support;

   - Implementation of risk-minimisation measures.

5. Greater focus on strategic activities

By assigning specific pharmacovigilance activities to a specialised team, companies can focus their internal resources on their core business activities while maintaining appropriate oversight of the pharmacovigilance system and outsourced activities.

Outsourcing does not remove the regulatory responsibilities of the Marketing Authorisation Holder. It does, however, allow those responsibilities to be managed through an efficient and properly controlled structure.

6. Proactive risk management

A robust pharmacovigilance system should enable the identification, assessment, characterisation and minimisation of risks associated with medicinal products.

An experienced service provider can support the early detection of potential safety issues, the consistent assessment of available information and the timely implementation of the necessary actions. This approach helps protect patients, regulatory compliance and the company’s reputation.

7. Increased speed and efficiency

A dedicated team familiar with regulatory requirements and timelines can perform pharmacovigilance activities more efficiently and consistently.

The use of defined processes, control mechanisms and clearly allocated responsibilities facilitates compliance with reporting, assessment, submission and follow-up timelines.

8. Access to specialised technology and processes

Service providers may offer systems and tools for managing safety cases, literature, signals, documentation, deadlines and performance indicators.

These solutions improve data traceability, facilitate the identification of patterns and trends and support more informed decision-making.

How should a pharmacovigilance partner be selected?

To obtain the full benefits of outsourcing, it is essential to select an experienced partner with an appropriate quality management system and the ability to adapt its services to each company’s specific needs.

Before selecting a service provider, companies should evaluate aspects such as:

   - The team’s experience and qualifications;

   - Knowledge of national and European requirements;

   - Quality management system;

   - Procedures and control mechanisms;

   - Data protection and confidentiality;

   - Business continuity and contingency management;

   - Technological capabilities;

   - Performance indicators;

   - Communication, oversight and escalation arrangements;

   - Allocation of responsibilities in a contract and pharmacovigilance agreement.

A solution tailored to each company’s needs

Zemir Pharma Consulting provides pharmacovigilance services adapted to the characteristics and needs of each client, ranging from support with specific activities to the integrated management of the pharmacovigilance system.

Our team combines regulatory experience, controlled processes and a close and flexible approach to support Marketing Authorisation Holders and other organisations throughout the entire medicinal product life cycle.

Are you looking for a partner to outsource all or part of your pharmacovigilance activities? Contact us to discuss your company’s needs and define the most appropriate solution.